Furthermore, elevated VDAC1 levels have been documented in the affected brain regions of AD postmortem samples (Yoo et al., 2001; Manczak and Reddy, 2012) and in the serum of AD patients (Sun et al., 2014). The gene discussed is VDAC1; the disease is Alzheimer disease.